Jim Cramer Says Investors Should Own Allergan, Shares are Undervalued
Jim Cramer says investors should own Allergan because the stock is undervalued.
TheStreet's Jim Cramer says investors should own Allergan (AGN) - Get Report because the stock is undervalued. Cramer says Allergan will benefit from the closing of the sale of its generics business to Teva Pharmaceuticals (TEVA) - Get Report for $40.5 billion.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
